Salvage Therapy

For some patients, initial induction therapy does not achieve remission. These patients are said to have primary resistant or refractory disease. Of those that do achieve remission with induction therapy, some will suffer a relapse within the 2 to 3 years following induction therapy. These patients are said to have relapsed disease. For both of these groups of patients, salvage therapy is required with the aim of inducing a first or second remission.

For patients with relapsed disease, treatment may involve a similar regimen to their first induction therapy. For many patients, particularly those who did not achieve a first remission, it will involve a different regimen made up of different chemotherapy and medication types known as salvage therapy or rescue therapy. A number of new anti-leukaemia medications have been developed for this purpose. Some patients who need salvage therapy enrol in a clinical trial designed for treatment of resistant or relapsed disease. 

 

Advertisement
Únete a Nuestra Comunidad Regístrate para Eventos Lee Nuestro Último Post
Advertisement

Page last updated on April 3, 2017